Treatment of Meningitis Caused by Vancomycin-Resistant Enterococcus faecium: High-Dose and Combination Daptomycin Therapy

Cerebrospinal Fluid Penetration of High-Dose Daptomycin in Suspected Staphylococcus aureus Meningitis

(2010) M Shawn Riser et al.   ANNALS OF PHARMACOTHERAPY

Attenuation of Cerebrospinal Fluid Inflammation by the Nonbacteriolytic Antibiotic Daptomycin versus That by Ceftriaxone in Experimental Pneumococcal Meningitis

(2010) D. Grandgirard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin

(2010) José M. Entenza et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy

(2009) Pamela A Moise et al.   ANNALS OF PHARMACOTHERAPY

Combination of Daptomycin plus Ceftriaxone Is More Active than Vancomycin plus Ceftriaxone in Experimental Meningitis after Addition of Dexamethasone

(2009) U. Egermann et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Safety of High‐Dose Intravenous Daptomycin Treatment: Three‐Year Cumulative Experience in a Clinical Program

(2009) D. A. Figueroa et al.   CLINICAL INFECTIOUS DISEASES

Telavancin: A Novel Lipoglycopeptide

(2009) Louis D. Saravolatz et al.   CLINICAL INFECTIOUS DISEASES

In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: Tigecycline Evaluation and Surveillance Trial 2004 to 2007

(2009) Mark W. Garrison et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Strategies and New Developments in the Management of Bacterial Meningitis

(2009) Justine Miranda et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Failure of linezolid therapy for post-neurosurgical meningitis due to Enterococcus faecium

(2009) D. P. Webster et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Daptomycin Therapy for Vancomycin-Resistant Enterococcal Bacteremia: A Retrospective Case Series of 30 Patients

(2009) Jason C Gallagher et al.   PHARMACOTHERAPY

Relationship of Linezolid Minimum Inhibitory Concentration and Time to Bacterial Eradication in Treatment for Methicillin-Resistant Staphylococcus Aureus Infection

(2008) Pamela A Moise et al.   ANNALS OF PHARMACOTHERAPY

Evaluation of Daptomycin Pharmacodynamics and Resistance at Various Dosage Regimens against Staphylococcus aureus Isolates with Reduced Susceptibilities to Daptomycin in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

(2008) W. E. Rose et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureus

(2008) N. Cotroneo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Successful Treatment of Methicillin‐ResistantStaphylococcus aureusMeningitis with Daptomycin

(2008) Dong Heun Lee et al.   CLINICAL INFECTIOUS DISEASES

Activity of serum concentrations of daptomycin vs. vancomycin against vancomycin-susceptible and resistant Enterococcus faecium in the presence of albumin physiological concentrations: an in vitro pharmacodynamic simulation

(2008) L. Alou et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

(2008) Alicia I. Hidron et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY